PTKFY:OTCMKTS
PT Kalbe Farma Unsponsored Indonesia ADR
US$ ९.७३
०.००%
(०.००) 1D
मे १३, १५:३३:३९ GMT-४ · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTKFY...
Mkt. cap
३.९३ शंख
Avg. vol.
७४.००
Volume
१२.००
52-wk high
US$ २१.१६
52-wk low
US$ ९.७३
Beta
०.०८
Shares outstanding
२३.४४ करोड
No. of employees
१३ हजार
News stories
From sources across the web
MSN
·
६ मिनेट पहिले
The S&P 500 and most of its stocks are heading in opposite directions at a record pace. What investors should know.
TipRanks
·
१२ मिनेट पहिले
Duke Robotics Completes Nasdaq Uplisting and Equity Offering
Yahoo Finance
·
२३ मिनेट पहिले
Stock market today: Dow, S&P 500, Nasdaq futures trade flat as inflation worries persist
CME Group
·
३३ मिनेट पहिले
S&P 500 futures closed lower amid Middle East headlines.
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About PT Kalbe Farma Unsponsored Indonesia ADR
AI content may include mistakes. Learn more